EI
CRL icon

Ellevest Inc’s Charles River Laboratories CRL Stock Holding History

Ellevest Inc’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-21
Closed -$4.24K – 633
2023
Q1 		$4.24K Sell
21
-23
-52% -$5.21K ﹤0.01% 1249
2022
Q4 		$9.59K Sell
44
-53
-55% -$11.6K ﹤0.01% 1037
2022
Q3 		$19K Sell
97
-99
-51% -$21.4K ﹤0.01% 824
2022
Q2 		$42K Sell
196
-229
-54% -$56K ﹤0.01% 603
2022
Q1 		$121K Buy
425
+181
+74% +$55.8K 0.01% 382
2021
Q4 		$92K Buy
244
+56
+30% +$21.8K 0.01% 404
2021
Q3 		$78K Hold
188
– – 0.01% 405
2021
Q2 		$70K Sell
188
-9
-5% -$3K 0.01% 420
2021
Q1 		$57K Buy
197
+112
+132% +$31.1K 0.01% 433
2020
Q4 		$21K Buy
85
+49
+136% +$11.7K ﹤0.01% 619
2020
Q3 		$8K Buy
36
+21
+140% +$4.36K ﹤0.01% 687
2020
Q2 		$3K Buy
+15
New +$2.39K ﹤0.01% 811
2019
Q2 		– Sell
-20
Closed -$3K – 396
2019
Q1 		$3K Buy
+20
New +$2.63K ﹤0.01% 262

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Ellevest Inc's CRL Position: Q2 2023 in Review

Ellevest Inc sold out of Charles River Laboratories (CRL) in Q2 2023, closing a stake of 21 shares — an estimated $4.24K sold.

Ellevest Inc first reported a position in CRL in Q1 2019 and held it in 13 quarters. The position peaked at $121K in Q1 2022. 612 funds tracked by Wall St. Rank hold CRL as of Q2 2023.

  • Ellevest Inc reported no remaining Charles River Laboratories position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 21 Charles River Laboratories shares in Q2 2023, an estimated $4.24K.
  • Ellevest Inc first reported a position in Charles River Laboratories in Q1 2019 and held it in 13 quarters.
  • Ellevest Inc's Charles River Laboratories position peaked at $121K in Q1 2022.
  • 612 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.